DorsaVI
DorsaVI (ASX: DVL) is an Australian-listed wearable motion analysis company that sells FDA-cleared ViMove+ clinical sensors, ViSafe+ workplace safety sensors, Video AI, and Research+ software to physical therapy clinics, elite sports teams, enterprise occupational health buyers, and defence customers, while pivoting via Artemis Labs toward RRAM semiconductors and robotics IP.
- Company typePublic
- Founded2008
- HeadquartersMelbourne, Australia
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What DorsaVI does
DorsaVI (ASX: DVL) is an Australian-listed biotechnology and motion analysis company founded in 2008 that develops FDA-cleared and TGA-certified wearable sensor systems for clinical, sports, occupational health, and defence applications. The company's core platform comprises ViMove+ (clinical and athletic movement analysis using wireless IMU sensors combining accelerometer, gyroscope, and magnetometer data), ViSafe+ (workplace safety sensors with surface EMG for ergonomic and manual handling risk assessment), Video AI (computer-vision movement analysis module), and Research+ (research-grade motion capture software). The company operates a database of over 10,000 proprietary knee assessments underpinning AI-powered injury-risk analytics, including a 3D knee motion analysis module launched in March 2025 that addresses limitations of traditional 1D force plates for ACL injury risk identification.
DorsaVI monetises through hardware sales of medical-grade wearable sensors paired with subscription and licence-based software (including the Video AI module), supplemented by clinical validation study contracts (e.g., Dr Patel collaboration, SEROMA European study) and emerging technology licensing revenue. Go-to-market is sales-led with 'Request a Demo' and 'Free Trial' CTAs, an online store for SMB and individual buyers, and a distribution partnership with Select Medical Network covering 120+ active clinical sites. The customer base spans SMB physical therapy clinics, sports medicine and elite sport customers, enterprise workplace safety deployments (Heathrow Airport, mining and utilities sectors), and government/defence applications including police tactical units.
Since 2024 the company has executed a significant strategic pivot toward semiconductor and AI hardware, launching wholly owned subsidiary Artemis Labs in August 2025, acquiring neuromorphic processing-in-memory technology from Technion, signing multi-year compute-in-memory RRAM co-development partnerships with ITRI (Taiwan) and NTU (Singapore), licensing exclusive worldwide robotics IP from NTU Singapore in June 2026, and launching the Sensor v6.5 Physical AI wearable in July 2026. The pivot targets robotics, rehabilitation exoskeletons, and ultra-edge AI applications, though FY25 revenue was AU$1.15M (a 14% YoY decline) against AU$3M annual cash burn, and the new lines have not yet produced material commercial revenue.
DorsaVI firmographics
Firmographics- Name
- DorsaVI
- Legal name
- dorsaVi Ltd
- Website
- https://dorsavi.com
- Company type
- Public
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- DorsaVI (ASX: DVL) is an Australian-listed wearable motion analysis company that sells FDA-cleared ViMove+ clinical sensors, ViSafe+ workplace safety sensors, Video AI, and Research+ software to physical therapy clinics, elite sports teams, enterprise occupational health buyers, and defence customers, while pivoting via Artemis Labs toward RRAM semiconductors and robotics IP.
- Ownership category
- akta.pro rank
DorsaVI industry classification
Industry- Product category
- Wearable Movement Analysis Technology
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)
- akta.pro secondary industry
- Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)
Keywords
Where DorsaVI is headquartered
LocationHeadquarters
- HQ city
- Melbourne
- HQ country
- Australia
- HQ region
- Oceania
Offices4 records
Markets served
DorsaVI business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations
Revenue model
- Wearable Sensor Hardware and Software: Medical-grade wearable devices and associated software platforms (ViMove+, ViSafe+, Research+) sold to clinical, sports, and workplace safety customers with recurring software/license components.
- Video AI Subscription: AI-powered video analysis technology offered as module subscription for movement assessment in gyms, clinics, and sporting clubs.
- Clinical Validation Contracts: Contracted revenue from clinical validation studies such as Dr Patel collaboration and SEROMA European study validating Ultra Edge platform and on-device AI capabilities.
- Technology Licensing: Revenue expected from expanded platform into collaborative robotics, rehabilitation exoskeletons and human-augmentation devices following NTU Singapore IP licensing.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
DorsaVI product offering
Product offeringCore offering
DorsaVi develops and sells FDA-cleared wearable movement analysis systems combining wireless IMU sensors with AI-powered video analysis for clinical rehabilitation, elite sports, workplace safety, and research applications. Its core platform ViMove+ captures objective biomechanical data for return-to-sport and injury prevention decisions, while ViSafe+ addresses occupational ergonomic risk and Research+ supports clinical and academic research. The company is also commercializing Sensor v6.5, an on-device Physical AI wearable, and 22nm RRAM semiconductor technology for robotics and ultra-edge AI.
Product overview
DorsaVI offers a unified movement intelligence platform centred on its FDA-cleared ViMove+ wearable sensor system, supplemented by Video AI (sensorless computer-vision movement analysis), ViSafe+ (workplace safety sensors), and Research+ (research-grade motion capture). The product portfolio operates as a platform-plus-modules architecture: ViMove+ serves as the core clinical and sports sensor, with Video AI providing a complementary sensorless video AI layer; ViSafe+ addresses the occupational health segment; and Research+ targets academic and clinical research. Legacy products (ViMove, ViPerform, myViSafe, Professional Suite) remain supported but are succeeded by the current generation. The company is expanding into adjacent markets through Artemis Labs (robotics/AI subsidiary), RRAM semiconductor technology development, and the Sensor v6.5 Physical AI wearable, as well as a licensed robotics IP portfolio from NTU Singapore for exoskeleton and collaborative robotics applications.
Differentiator
Problem solved
Functional benefit
Brands
- Artemis Labs: Wholly owned subsidiary focused on advancing robotics, artificial intelligence, and sensor technologies, including RRAM semiconductor technology for edge AI and robotics applications.
- ViMove+
- ViSafe+
- Video AI
- Research+
Products and services
- ViMove+ FDA-cleared wireless IMU wearable sensor platform using accelerometer, gyroscope, and magnetometer for clinical and athletic movement analysis, supporting return-to-sport assessment, rehabilitation monitoring, injury prevention, and ACL injury-risk screening in physical therapy, elite sport, and defence applications.
- Video AI AI-powered sensorless video technology that performs running gait analysis and upper/lower limb movement evaluations using computer vision to detect movement angles and provide real-time visual feedback on asymmetries and movement inefficiencies, offered as a module subscription for clinics, gyms, and sporting clubs.
- ViSafe+ Industrial software paired with wearable sensors and sEMG electrodes for comprehensive manual handling assessments, identifying ergonomic risk patterns, detecting muscle fatigue, validating safety interventions, and supporting safer work practices through objective movement data in workplaces such as airports, mining, utilities, and logistics.
- Research+ Advanced research software and wearable sensors with a library of algorithms for dynamic movement assessment, supporting kinematic metrics and EMG integration with flexible sampling configurations for laboratory, field, academic, pharmaceutical, and clinical research applications.
- Sensor v6.5 First commercially-ready Physical AI wearable from dorsaVi that performs movement analysis and delivers real-time biofeedback directly on the device without requiring cloud connectivity or a base device, completing the measure-analyse-decide-act loop within milliseconds at the point of movement, built on the FDA-cleared and TGA-certified movement analysis platform.
Quantifiable outcome
- 53% reduction in manual handling injuries at Heathrow Airport baggage handlers within one year
- +6 more outcomes
Companies that use DorsaVI
Customer profileNamed customers11 records
Segments4 records
Ideal customer profiles3 records
DorsaVI technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature12 records
DorsaVI partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, minor and key.
- Nanyang Technological University Singapore (NTU Singapore)coreDorsaVi signed an exclusive worldwide 10-year licence agreement to acquire two robotics IP assets covering human-robot collaboration safety systems, including a universal control framework and multimodal data collection methodology. Total consideration of SGD 290,000 over the term with no product-sale royalties. Deal positioned to expand platform from wearable sensing into collaborative robotics, rehabilitation exoskeletons and human-augmentation devices.
- Artemis LabscoreWholly owned subsidiary launched by dorsaVi to consolidate R&D efforts in robotics, AI, and sensor technologies, aiming to deliver neuromorphic systems for healthcare and robotics applications. Positioned to integrate FDA-cleared movement analytics with RRAM semiconductor technology.
- ITRI (Taiwan)coreMulti-year partnership established to develop compute-in-memory RRAM technology targeting robotics and ultra-edge AI applications. Part of dorsaVi's strategic pivot toward semiconductor innovation for next-generation intelligent physical systems.
- NTU (Singapore)coreMulti-year partnership for RRAM technology development targeting robotics and ultra-edge AI, complementing the robotics IP licensing agreement.
- Technion (Professor Shahar Kvatinsky)coreAcquisition of neuromorphic processing-in-memory technology from Technion - human brain-inspired computing enabling memory chips to process data simultaneously rather than following energy-intensive Von Neumann model.
- Dr Patelminor8-month clinical collaboration developing lower-limb analytics module for ViMove+ targeting 2026 revenue. Part of Ultra Edge platform validation totaling over A$200,000 in contracted revenue.
- SEROMA Study (European)minorEuropean clinical study deploying ViMove+ across six sites for axial spondyloarthritis with three pharmaceutical groups using on-device AI for real-time metrics. Part of A$200,000+ contracted revenue validation.
- Select Medical NetworkkeyHealthcare network with over 120 active sites using ViMove+ for clinical movement analysis. Major distribution channel partnership for clinical segment.
Scale indicators17 records
Recent moves6 records
Expansion highlights6 records
DorsaVI competitors and assessment
Company assessmentDirect peers
- Qualisys: Provider of optical and inertial motion capture systems for clinical biomechanics, research, and sports — competing in the Research+ and clinical movement analysis segments alongside DorsaVi.
- Noraxon USA: Provides EMG and IMU-based biomechanics systems used in clinical research, sports, and rehabilitation — comparable to DorsaVi's Research+ and ViMove+ offerings with overlapping customers in physical therapy and sports medicine.
- BTS Bioengineering: Provides gait analysis, motion capture, and EMG systems (including SMART-DX and P-Walk) for clinical rehabilitation and sports performance — directly overlapping with DorsaVi's ViMove+ clinical/sports offering.
- Kinetic: Provides wearable-based workplace injury prevention and ergonomics platform targeting enterprises — directly comparable to DorsaVi's ViSafe+ workplace safety offering with overlapping customers in logistics, manufacturing, and industrial segments.
- Xsens (Movella): Manufacturer of MVN inertial motion capture systems using IMUs for biomechanics, animation, and clinical/research applications — competing technology and use cases as DorsaVi's Research+ and ViMove+ sensors.
- APDM Wearable Technologies (Clario): Makers of Opal wearable inertial sensors for clinical movement assessment in Parkinson's, ALS, MS, and other neurological conditions — directly comparable technology stack and clinical/sports end markets to DorsaVi.
- Delsys: Specialises in surface EMG sensors (Trigno) for clinical research, sports, and rehabilitation — directly comparable to DorsaVi's ViSafe+ sEMG capabilities for muscle activity monitoring in clinical and workplace settings.
- Vald Health: Australian-based clinical biomechanics company offering ForceFrame, NordBord, and HumanTrak wearable/connected systems for physical therapy, sports, and clinical movement assessment — directly competitive with DorsaVi's ViMove+ clinical positioning.
Broad incumbents
- Catapult Sports: Established athlete wearable tracking vendor serving elite sports teams with GPS/IMU-based athlete monitoring — comparable in end market (elite sports) and sensor-based wearable technology, though with a broader portfolio than DorsaVi.
Emerging players
- Tekscan: Manufacturer of pressure mapping systems used in gait, foot biomechanics, and clinical assessment — adjacent technology and clinical/rehab end markets that overlap with DorsaVi's lower-limb and movement analysis use cases.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
DorsaVI social profiles
Digital presenceDorsaVI compliance and trust
Trust signalCompliance4 records
DorsaVI financial estimates
Financial estimateRevenue estimate
Valuation estimate
DorsaVI leadership team
Management profileNumber of profiles
Profiles3 records
DorsaVI subsidiaries and ownership
Company hierarchySubsidiaries2 records
DorsaVI funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DorsaVI M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DorsaVI
What does DorsaVI do?
DorsaVi develops and sells FDA-cleared wearable movement analysis systems combining wireless IMU sensors with AI-powered video analysis for clinical rehabilitation, elite sports, workplace safety, and research applications. Its core platform ViMove+ captures objective biomechanical data for return-to-sport and injury prevention decisions, while ViSafe+ addresses occupational ergonomic risk and Research+ supports clinical and academic research. The company is also commercializing Sensor v6.5, an on-device Physical AI wearable, and 22nm RRAM semiconductor technology for robotics and ultra-edge AI.
Is DorsaVI a public or private company?
DorsaVI is a public company. It is classified as public and is currently operating.
When was DorsaVI founded?
DorsaVI was founded in 2008. It employs 11 to 50 people.
Where is DorsaVI based?
DorsaVI is headquartered in Melbourne, Australia, in the Oceania region.
How does DorsaVI make money?
Four revenue lines are on record. Wearable Sensor Hardware and Software is the primary driver. The others are video AI Subscription, clinical Validation Contracts and technology Licensing.
Who are DorsaVI's main competitors?
Direct peers on record are Qualisys, Noraxon USA, BTS Bioengineering, Kinetic, Xsens (Movella), APDM Wearable Technologies (Clario), Delsys and Vald Health. Catapult Sports is listed as a broad incumbent. Tekscan is listed as an emerging player.
Does DorsaVI have an API?
No public API is recorded for DorsaVI.
What industry is DorsaVI in?
DorsaVI's product category is Wearable Movement Analysis Technology. Its primary akta.pro industry code is HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables), with a secondary code of HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices). Its NAICS code is 334510 and its SIC code is 3845.